Diabetes mellitus: an opportunity for therapy with stem cells?

Related Experiment Video

Updated: Jul 5, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

Valeria Sordi1, Federico Bertuzzi, Lorenzo Piemonti

  • 1Laboratory of Experimental Surgery, San Raffaele Scientific Institute, via Olgettina 60, 20132 Milan, Italy.

Regenerative Medicine
|May 9, 2008
PubMed

Insights

Restoring insulin-producing beta-cells is key for diabetes treatment. Regenerative medicine strategies, including stem cell differentiation and cell conversion, show promise but require further research for therapeutic application.

Area of Science:

  • Endocrinology
  • Regenerative Medicine
  • Developmental Biology

Background:

  • Type 1 and Type 2 diabetes are characterized by insufficient insulin-producing beta-cells, leading to poor blood glucose control and complications.
  • Restoring beta-cell mass through endocrine pancreas regeneration is a potential therapeutic strategy.

Purpose of the Study:

  • To review current strategies for generating insulin-secreting cells for diabetes treatment.
  • To highlight advances and remaining challenges in beta-cell regeneration.

Main Methods:

  • Investigating the potential of adult pancreatic stem/progenitor cells.
  • Exploring the conversion of differentiated cells (e.g., hepatocytes) into beta-cells.
  • Utilizing embryonic stem cell differentiation into beta-cells.
  • Pursuing enhanced in vivo and in vitro beta-cell proliferation.

Main Results:

  • Significant progress has been made in directing embryonic stem cell differentiation into beta-cells.
  • Research is exploring cell conversion and stem cell-based approaches for beta-cell generation.
  • In vivo and in vitro beta-cell proliferation strategies are under investigation for regenerative medicine.

Conclusions:

  • Current regenerative medicine approaches for diabetes, including stem cell differentiation and cell conversion, show encouraging results.
  • Major gaps in understanding pancreatic developmental biology and adult beta-cell dynamics need to be addressed before therapeutic applications.
  • Further research is essential to bridge knowledge gaps for successful clinical translation of beta-cell regeneration therapies.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...